WHA67 May 2014
Downloading
Complete integrated commentary including item analysis and links to key documents: download here.
Specific item commentaries
All of the item-specific webpages linked from this page ("PHM comment", below) are created in Google docs. Note these pages include Notes of WHA67 debate. To download these pages, navigate to the relevant Gdoc page, hit the <double down arrow> in the top right hand corner to show the menu bar. Now select File > Download and choose your preferred file format.
Agenda
1. Opening of the Health Assembly
1.2 Election of the President
1.3 Election of the five Vice-Presidents, the Chairmen of the main committees, and
establishment of the General Committee
1.4 Adoption of the agenda and allocation of items to the main committees
(A67/1)
2. Report of the Executive Board on its 133rd and 134th sessions
(A67/2)
3. Address by Dr Margaret Chan, Director-General (A67/3)
4. Invited speaker
5. Admission of new Members and Associate Members [if any]
6. Executive Board: election
7. Awards
8. Reports of the main committees
9. Closure of the Health Assembly
COMMITTEE A
10. Opening of the Committee
11. WHO reform
11.1 Reform implementation plan and report (PHM comment).
11.2 Improved decision-making by the governing bodies (PHM comment)
11.3 Framework of engagement with non-State actors (PHM comment) (MMI-PHM Statement)
11.4 Financing dialogue (PHM comment)
11.5 Strategic resource allocation (PHM comment)
11.6 Financing of administrative and management costs (PHM comment)
12. Communicable diseases
12.1 Global strategy and targets for tuberculosis prevention, care and control after 2015. (PHM comment) (MMI-PHM Statement)
12.2 Global vaccine action plan (PHM comment)
12.3 Hepatitis (PHM comment) (MMI-PHM statement)
13. Noncommunicable diseases
13.1 Follow up to the Political Declaration of the High-level Meeting of the General Assembly
on the Prevention and Control of Non-communicable Diseases (PHM comment) (MMI-PHM Statement)
13.2 Maternal, infant and young child nutrition (PHM comment)
13.3 Disability (PHM comment)
13.4 Comprehensive and coordinated efforts for the management of autism spectrum disorders (PHM comment)
13.5 World psoriasis day (PHM comment) (MMI-PHM statement)
14. Promoting health through the life course
14.1 Monitoring the achievement of the health-related Millennium Development Goals including Health in the post-2015 development agenda (PHM comment) (MMI-PHM statement)
14.2 Newborn health: draft action plan (PHM comment)
14.3 Addressing the global challenge of violence, in particular against women and girls (PHM comment)
14.4 Multisectoral action for a life course approach to healthy ageing (PHM comment)
14.5 Public health impacts of exposure to mercury and mercury compounds: the role of WHO
and ministries of public health in the implementation of the Minamata Convention (PHM comment)
14.6 Contributing social and economic development: sustainable action across sectors to
improve health and health equity (PHM comment)
15. Health systems
15.1 Traditional medicine (PHM comment)
15.2 Follow-up of the report of the Consultative Expert Working Group on Research and
Development: Financing and Coordination (PHM comment)
15.3 Substandard/spurious/falsely-labelled/falsified/counterfeit medical products (PHM comment)
15.4 Access to essential medicines (PHM comment) (MMI-PHM statemnt)
15.5 Strengthening of palliative care as a component of integrated treatment throughout the
life course (PHM comment)
15.6 Regulatory system strengthening (PHM comment) (MMI-PHM Statement)
15.7 Health intervention and technology assessment in support of universal health coverage (PHM comment)
15.8 Follow-up of the Recife Political Declaration on Human Resources for Health: renewed
commitments towards universal health coverage (PHM comment) (MMI-PHM statement)
16. Preparedness, surveillance and response
16.1 Implementation of the International Health Regulations (2005) (PHM comment)
16.2 Pandemic influenza preparedness: sharing of influenza viruses and access to vaccines and other benefits (PHM comment) (MMI-PHM-TWN Statement)
16.3 Smallpox eradication: destruction of variola virus stocks (PHM comment) (MMI-PHM-TWN statement)
16.4 Poliomyelitis: intensification of the global eradication initiative (PHM comment)
16.5 Antimicrobial drug resistance (PHM comment)
17. Progress reports
See Progress Reports, at A67/40, and also PHM page which provides links to the resolutions being followed up.
COMMITTEE B
18. Opening of the Committee
19. Health conditions in the occupied Palestinian territory, including east Jerusalem, and in the occupied Syrian Golan
(A67/41, A67/INF./2, A67/INF./3). PHM comment
20. Programme budget and financial matters
20.1 Programme budget 2012–2013: performance assessment
(A67/42) See PHM Comment.
20.2 Financial report and audited financial statements for the period 1 January 2013–31 December 2013 (A67/43 and A67/43 Add.1). See PHM Comment.
20.3 Status of collection of assessed contributions, including Member States in arrears in the payment of their contributions to an extent that would justify invoking Article 7 of the Constitution (A67/44)
PHM report
20.4 Special arrangements for settlement of arrears [if any]
20.5 Assessment of new Members and Associate Members [if any]
20.6 Amendments to the Financial Regulations and Financial Rules
21. Audit and oversight matters
21.1 Report of the External Auditor (A67/45)
PHM report
21.2 Report of the Internal Auditor (A67/46)
PHM report
22. Staffing matters
22.1 Human resources: annual report (A67/47) PHM Comment
22.2 Report of the International Civil Service Commission (A67/48)
22.3 Amendments to the Staff Regulations and Staff Rules (A67/49, EB134/2014/REC/1, and resolution EB134.R12)
22.4 Appointment of representatives to the WHO Staff Pension Committee (A67/50)
23. Management and legal matters
23.1 Follow-up of the report of the Working Group on the Election of the Director-General of the World Health Organization (A67/51)
23.2 Real estate: update of the Geneva buildings renovation strategy (A67/52, NYP, presumably a revision of EB134/41)
24. Collaboration within the United Nations system and with other intergovernmental organizations (A67/53)
Attachment | Size |
---|---|
WHA67_PHMCommentary_140519.pdf | 712.13 KB |
MMI-PHM Statement_NCDs.pdf | 59.73 KB |
MMI-PHM Statement_MDGs.pdf | 70.12 KB |
MMI-PHM Statement_Psoriasis.pdf | 70.33 KB |
MMI-PHM Statement_Smallpox.pdf | 70.02 KB |
MMI-PHM Statement_EssentialDrugs.pdf | 74.65 KB |
MMI-PHM Statement_Hepatitis.pdf | 70.87 KB |
MMI-PHM Statement_12-1_TB.pdf | 339.15 KB |
MMI-PHM Statement_15-6_RegulatorySystemStrengthening.pdf | 261.29 KB |
MMI-PHM Statement_11-3_NSAs.pdf | 26.21 KB |
MMI-PHM Statement_15-8_RecifeDeclaration.pdf | 579.13 KB |
MMI-PHM Statement_16-2-PIP.pdf | 25.82 KB |